1-5 of 5
Anju Karki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2031: A phase 1b/2 clinical study of onvansertib in combination with FOLFIRI/bevacizumab revealed a new role of PLK1 in regulating the hypoxia pathway in KRAS-mutant colorectal cancer

Maya Ridinger, Anju Karki, Ramanand A. Subramanian, Errin Samuelsz, Divora Yemane, Roy Kim, Chu-Chiao Wu, Fairooz F. Kabbinavar, Tod Smeal, Heinz-Josef Lenz
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2031.
https://doi.org/10.1158/1538-7445.AM2024-2031
Published: 22 March 2024
View articletitled, Abstract 2031: A phase 1b/2 clinical study of onvansertib in combination with FOLFIRI/bevacizumab revealed a new role of PLK1 in regulating the hypoxia pathway in KRAS-mutant colorectal cancer
Journal Articles

Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy

Zhuangzhuang Zhang, Lijun Cheng, Jie Li, Qi Qiao, Anju Karki, Derek B. Allison, Nuha Shaker, Kunyu Li, Sagar M. Utturkar, Nadia M. Atallah Lanman, Xiongjian Rao, Piotr Rychahou, Daheng He, Stephen F. Konieczny, Chi Wang, Qing Shao, B. Mark Evers, Xiaoqi Liu
Journal: Cancer Research
Cancer Res (2022) 82 (19): 3532–3548.
https://doi.org/10.1158/0008-5472.CAN-22-0018
Published: 04 October 2022
View articletitled, Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
Open the PDF for Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract B37: Assessing DNA damage response pathway proteins ATM and p53 in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein

Anju Karki, Khashayar Vakili, Antonio R. Perez-Atayde
Journal: Cancer Research
Cancer Res (2018) 78 (19_Supplement): B37.
https://doi.org/10.1158/1538-7445.PEDCA17-B37
Published: 01 October 2018
View articletitled, Abstract B37: Assessing DNA damage response pathway proteins ATM and p53 in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein
Journal Articles

Abstract 4150: MDM4 expression is increased in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein

Anju Karki, Juan Putra, Michael LaQuaglia, Antonio Perez-Atayde, Khashayar Vakili
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4150.
https://doi.org/10.1158/1538-7445.AM2018-4150
Published: 01 July 2018
View articletitled, Abstract 4150: MDM4 expression is increased in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein
Journal Articles

Abstract 3514: Assessing the role of CREB in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein

Anju Karki, Michael J. LaQuaglia, Amanda M. Dios, Ghazaleh Sadri-Vakili, Khashayar Vakili
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3514.
https://doi.org/10.1158/1538-7445.AM2017-3514
Published: 01 July 2017
View articletitled, Abstract 3514: Assessing the role of CREB in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein